Hong Fang Song
Direttore/Membro del Consiglio presso CG ONCOLOGY, INC.
Patrimonio netto: 19 M $ in data 30/06/2024
Profilo
Hong Fang Song is currently an Independent Director at CG Oncology, Inc. and a Director at Enable Injections, Inc. She previously worked as a Managing Director at Cowen, Inc. She holds a graduate degree from Claremont Graduate University and an undergraduate degree from Fudan University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CG ONCOLOGY, INC.
0.92% | 25/03/2024 | 613 928 ( 0.92% ) | 19 M $ | 30/06/2024 |
Posizioni attive di Hong Fang Song
| Società | Posizione | Inizio |
|---|---|---|
| CG ONCOLOGY, INC. | Direttore/Membro del Consiglio | 01/11/2015 |
Enable Injections, Inc.
 Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Hong Fang Song
| Società | Posizione | Fine |
|---|---|---|
| COWEN INC. | Corporate Officer/Principal | - |
Formazione di Hong Fang Song
| Fudan University | Undergraduate Degree |
| Claremont Graduate University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Enable Injections, Inc.
Enable Injections, Inc. Medical SpecialtiesHealth Technology Enable Injections, Inc. develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH. | Health Technology |
Cowen, Inc.
 Cowen, Inc. Investment Banks/BrokersFinance Cowen, Inc. engages in the provision of financial services. It operates through following the segments: Operating Company and Asset Company. The Operating Company segment consists of the Cowen Investment Management, Investment Banking, Markets, and Research divisions. The Asset Company segment consists of the firm’s private investments, private real estate investments, and other legacy investment strategies. The firm offers investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services, and actively managed alternative investment products. The company was founded in 1918 and is headquartered in New York, NY. | Finance |
- Borsa valori
- Insiders
- Hong Fang Song
